Project Number 5R01AG054029-02 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator SPERLING, REISA A. Principal Investigator First Name REISA A. Principal Investigator Last Name SPERLING Awardee Organization BRIGHAM AND WOMEN'S HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-364: Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01) FY Overall Cost $3,981,411 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
